The effect of combine fentanyl and midazolam on pain management and prevention of chronic pai
Phase 2
Recruiting
- Conditions
- Control of pain and prevention of chronic pain in patients with lower limb fracture.Fracture of femur
- Registration Number
- IRCT20111009007745N10
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
30-60 years old patients with isolated femoral fractures who are not candidated for emergency surgery
Exclusion Criteria
Patients with a history of diabetes, addiction, hypertension, or oral pain relief intake drugs, or history of chronic pain
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain control and prevention of chronic pain in patients with lower limb fractures by Fentanyl Infusion and Midazolam. Timepoint: The effect of fentanyl and midazolam infusion on pain management and prevention of chronic pain in patients with lower extremity fracture The patient's pain is evaluated after five hours, 15 hours, 24 hours from the time of admission and starting the infusion drugs. In 24 hours after the operation, the same procedure is measured 5, 15, 24 hours after the operation. After discharge from the hospital, follow-up is done on monthly through with questionnaires mentioned, and all patients were monitored for 6 months. Method of measurement: Based on McGill's Modified Inventory and Visual Analog Scale.
- Secondary Outcome Measures
Name Time Method Quality of life score. Timepoint: Quality of life scores are assessed 1, 3, and 6 months after discharge from the hospital. Method of measurement: Short questionnaire 12 health questions (SF12), designed by War, Kasinski, Keller.